Cargando…
Pathological complete response from oral chemotherapy combined with trans-arterial chemotherapy and embolization in an unresectable gastric cancer patient: A case report
RATIONALE: Gastric cancer is still one of the most common cancer in East Asia. More than 70% gastric cancer patients are diagnosed at an advanced stage in China. Moreover, about 10% cases are unresectable which usually suffer a poor prognosis with a median survival time of 5 to 12 months. In recent...
Autores principales: | Su, Zhaoran, Shu, Kuanshan, Kang, Min, Wang, Guihe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636947/ https://www.ncbi.nlm.nih.gov/pubmed/31232946 http://dx.doi.org/10.1097/MD.0000000000016075 |
Ejemplares similares
-
Clinical Complete Response after Chemotherapy and Palliative Surgery for Unresectable Gastric Cancer
por: Shishida, Masayuki, et al.
Publicado: (2020) -
Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma
por: Tsai, Wei-Lun, et al.
Publicado: (2020) -
Programmed Chemotherapy for Patients with Metastatic Unresectable Gastric Cancer
por: Shinoda, Masataka, et al.
Publicado: (2012) -
Combined intra-arterial and intravenous chemotherapy for unresectable, advanced gastric cancer has an improved curative effect compared with intravenous chemotherapy only
por: Wang, Jinfeng, et al.
Publicado: (2018) -
Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
por: Lee, S-H, et al.
Publicado: (2004)